Hyperacute antiplatelet therapy

In July 2020, the Australian Stroke Clinical Registry (AuSCR) implemented changes to the ‘hyperacute aspirin’ variables to enable the registry to better capture hyperacute antiplatelet therapy.  To guide correct data entry, see the following documents:

AuSCR hyperacute antiplatelets FAQ

AuSCR hyperacute antiplatelets example scenarios

We also conducted a webinar to introduce the changes, featuring Professor Richard Lindley.  Click here to view the webinar.

Button Back to FAQs